NO20071915L - Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer - Google Patents
Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorerInfo
- Publication number
- NO20071915L NO20071915L NO20071915A NO20071915A NO20071915L NO 20071915 L NO20071915 L NO 20071915L NO 20071915 A NO20071915 A NO 20071915A NO 20071915 A NO20071915 A NO 20071915A NO 20071915 L NO20071915 L NO 20071915L
- Authority
- NO
- Norway
- Prior art keywords
- protein kinase
- kinase inhibitors
- compounds useful
- diaminotriazole
- diaminotriazole compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Foreliggende oppfinnelse vedrører inhibitorer av proteinkinaser, spesielt inhibitorer av JAK2 og JAK3. Oppfinnelsen tilveiebringer også farmasøytiske sammensetninger omfattende forbindelsene ifølge oppfinnelsen, fremgangsmåter for å fremstille forbindelsene og metoder for å anvende sammensetningene i behandlingen av forskjellige forstyrrelser.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61090204P | 2004-09-17 | 2004-09-17 | |
PCT/US2005/033333 WO2006034116A1 (en) | 2004-09-17 | 2005-09-19 | Diaminotriazole compounds useful as protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20071915L true NO20071915L (no) | 2007-05-18 |
Family
ID=35583429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20071915A NO20071915L (no) | 2004-09-17 | 2007-04-16 | Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer |
Country Status (22)
Country | Link |
---|---|
US (1) | US7329652B2 (no) |
EP (1) | EP1791830B1 (no) |
JP (3) | JP5116092B2 (no) |
KR (1) | KR20070057955A (no) |
CN (1) | CN101039933B (no) |
AT (1) | ATE493401T1 (no) |
AU (1) | AU2005286968A1 (no) |
CA (1) | CA2580610C (no) |
CY (1) | CY1112253T1 (no) |
DE (1) | DE602005025655D1 (no) |
DK (1) | DK1791830T3 (no) |
ES (1) | ES2359007T3 (no) |
IL (1) | IL181987A0 (no) |
MX (1) | MX2007003154A (no) |
NO (1) | NO20071915L (no) |
NZ (1) | NZ580450A (no) |
PL (1) | PL1791830T3 (no) |
PT (1) | PT1791830E (no) |
RU (1) | RU2443700C2 (no) |
SI (1) | SI1791830T1 (no) |
WO (1) | WO2006034116A1 (no) |
ZA (1) | ZA200702645B (no) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5153777B2 (ja) * | 2006-10-02 | 2013-02-27 | アイアールエム・リミテッド・ライアビリティ・カンパニー | タンパク質キナーゼとしての化合物および組成物 |
ES2460894T3 (es) | 2006-12-29 | 2014-05-14 | Rigel Pharmaceuticals, Inc. | Triazoles sustituidos con heteroarilo policíclico útiles como inhibidores de Axl |
AU2016259396B2 (en) * | 2006-12-29 | 2018-11-08 | Rigel Pharmaceuticals, Inc. | Substituted triazoles useful as Axl inhibitors |
ES2656496T3 (es) | 2006-12-29 | 2018-02-27 | Rigel Pharmaceuticals, Inc. | Triazoles sustituidos útiles como inhibidores de AXL |
CA2710230C (en) | 2006-12-29 | 2016-02-23 | Rigel Pharmaceuticals, Inc. | Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
WO2008083353A1 (en) | 2006-12-29 | 2008-07-10 | Rigel Pharmaceuticals, Inc. | Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
ES2607065T3 (es) | 2006-12-29 | 2017-03-29 | Rigel Pharmaceuticals, Inc. | Triazoles N3-heteroaril sustituidos y triazoles N5-heteroaril sustituidos útiles como inhibidores de axl |
AU2014200824B2 (en) * | 2006-12-29 | 2016-12-15 | Rigel Pharmaceuticals, Inc. | Substituted triazoles useful as Axl inhibitors |
EA200901654A1 (ru) * | 2007-06-15 | 2010-06-30 | Айрм Ллк | Ингибиторы и способы с их использованием |
US8440701B2 (en) * | 2007-10-18 | 2013-05-14 | Janssen Pharmaceutica Nv | Trisubstituted 1,2,4 triazoles |
JO2784B1 (en) * | 2007-10-18 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | 5,3,1 - Triazole substitute derivative |
US7935693B2 (en) | 2007-10-26 | 2011-05-03 | Rigel Pharmaceuticals, Inc. | Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors |
KR101564303B1 (ko) * | 2008-03-19 | 2015-11-06 | 얀센 파마슈티카 엔.브이. | 니코틴성 아세틸콜린 수용체 조절제로서의 삼치환된 1,2,4-트리아졸 |
EP2280945B1 (en) * | 2008-05-09 | 2014-09-03 | Janssen Pharmaceutica, N.V. | Trisubstituted pyrazoles as acetylcholine receptor modulators |
DK2328888T3 (da) | 2008-07-09 | 2013-02-11 | Rigel Pharmaceuticals Inc | Broforbundne, bicykliske heteroarylsubstituerede triazoler, der er anvendelige som axl-inhitorer |
SG172997A1 (en) | 2009-01-16 | 2011-08-29 | Rigel Pharmaceuticals Inc | Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer |
RU2544862C2 (ru) * | 2009-06-09 | 2015-03-20 | Актелион Фармасьютиклз Лтд | Фторированные аминотриазольные производные |
AR080933A1 (es) | 2010-04-20 | 2012-05-16 | Ab Science | Tratamiento de esclerosis multiple con masitinib |
LT2841428T (lt) | 2012-04-24 | 2018-12-10 | Vertex Pharmaceuticals Incorporated | Dnr-pk inhibitoriai |
WO2014013014A1 (en) | 2012-07-18 | 2014-01-23 | Fundació Privada Centre De Regulació Genòmica (Crg) | Jak inhibitors for activation of epidermal stem cell populations |
EP3527563B1 (en) | 2013-03-12 | 2021-09-01 | Vertex Pharmaceuticals Incorporated | Dna-pk inhibitors |
CN105814036B (zh) | 2013-10-17 | 2018-10-26 | 沃泰克斯药物股份有限公司 | 作为dna-pk抑制剂的共晶 |
WO2018041989A1 (en) | 2016-09-02 | 2018-03-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing and treating refractory celiac disease type 2 |
KR20190062485A (ko) | 2016-09-27 | 2019-06-05 | 버텍스 파마슈티칼스 인코포레이티드 | Dna-손상제 및 dna-pk 저해제의 조합을 사용한 암 치료 방법 |
BR112021018168B1 (pt) | 2019-03-21 | 2023-11-28 | Onxeo | Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer |
WO2020201362A2 (en) | 2019-04-02 | 2020-10-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting and preventing cancer in patients having premalignant lesions |
EP3955920A1 (en) | 2019-04-16 | 2022-02-23 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Use of jak inhibitors for the treatment of painful conditions involving nav1.7 channels |
KR102133595B1 (ko) | 2019-05-31 | 2020-07-13 | 에이치케이이노엔 주식회사 | 단백질 키나제 억제제로서의 헤테로고리 화합물 |
KR102112336B1 (ko) | 2019-08-12 | 2020-05-18 | 에이치케이이노엔 주식회사 | 단백질 키나제 억제제로서의 헤테로고리 화합물 |
EP4054579A1 (en) | 2019-11-08 | 2022-09-14 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
WO2023222565A1 (en) | 2022-05-16 | 2023-11-23 | Institut National de la Santé et de la Recherche Médicale | Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5637592A (en) * | 1994-07-12 | 1997-06-10 | Janssen Pharmaceutica N.V. | Acyl derivatives of azolones |
GB9622363D0 (en) * | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
JP4495257B2 (ja) * | 1997-02-19 | 2010-06-30 | バーレツクス ラボラトリーズ インコーポレーテツド | Nos抑制剤としてのn−複素環誘導体 |
RU2340611C2 (ru) * | 2000-09-15 | 2008-12-10 | Вертекс Фармасьютикалз Инкорпорейтед | Производные пиразола, используемые в качестве ингибиторов протеинкиназы |
EP2316834A1 (en) * | 2002-05-06 | 2011-05-04 | Vertex Pharmaceuticals Incorporated | Thiadiazoles or oxadiazoles and their use as inhibitors of JAK protein kinase |
TWI335913B (en) * | 2002-11-15 | 2011-01-11 | Vertex Pharma | Diaminotriazoles useful as inhibitors of protein kinases |
AU2003293376A1 (en) * | 2002-12-10 | 2004-06-30 | Imclone Systems Incorporated | Anti-angiogenic compounds and their use in cancer treatment |
JP4889489B2 (ja) | 2003-08-06 | 2012-03-07 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼのインヒビターとして有用なアミノトリアゾール化合物 |
-
2005
- 2005-09-19 MX MX2007003154A patent/MX2007003154A/es active IP Right Grant
- 2005-09-19 ES ES05799808T patent/ES2359007T3/es active Active
- 2005-09-19 ZA ZA200702645A patent/ZA200702645B/xx unknown
- 2005-09-19 KR KR1020077008732A patent/KR20070057955A/ko not_active Application Discontinuation
- 2005-09-19 DK DK05799808.0T patent/DK1791830T3/da active
- 2005-09-19 CA CA2580610A patent/CA2580610C/en not_active Expired - Fee Related
- 2005-09-19 PT PT05799808T patent/PT1791830E/pt unknown
- 2005-09-19 EP EP05799808A patent/EP1791830B1/en active Active
- 2005-09-19 AU AU2005286968A patent/AU2005286968A1/en not_active Abandoned
- 2005-09-19 CN CN2005800353178A patent/CN101039933B/zh not_active Expired - Fee Related
- 2005-09-19 US US11/230,221 patent/US7329652B2/en not_active Expired - Fee Related
- 2005-09-19 SI SI200531255T patent/SI1791830T1/sl unknown
- 2005-09-19 AT AT05799808T patent/ATE493401T1/de active
- 2005-09-19 WO PCT/US2005/033333 patent/WO2006034116A1/en active Application Filing
- 2005-09-19 RU RU2007114293/04A patent/RU2443700C2/ru not_active IP Right Cessation
- 2005-09-19 JP JP2007532549A patent/JP5116092B2/ja not_active Expired - Fee Related
- 2005-09-19 NZ NZ580450A patent/NZ580450A/en not_active IP Right Cessation
- 2005-09-19 DE DE602005025655T patent/DE602005025655D1/de active Active
- 2005-09-19 PL PL05799808T patent/PL1791830T3/pl unknown
-
2007
- 2007-03-18 IL IL181987A patent/IL181987A0/en unknown
- 2007-04-16 NO NO20071915A patent/NO20071915L/no not_active Application Discontinuation
-
2008
- 2008-08-29 JP JP2008222676A patent/JP2009019048A/ja not_active Withdrawn
-
2011
- 2011-03-24 CY CY20111100321T patent/CY1112253T1/el unknown
-
2013
- 2013-02-12 JP JP2013024247A patent/JP2013082756A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2013082756A (ja) | 2013-05-09 |
DE602005025655D1 (de) | 2011-02-10 |
ZA200702645B (en) | 2008-08-27 |
ES2359007T3 (es) | 2011-05-17 |
PT1791830E (pt) | 2011-04-04 |
WO2006034116A1 (en) | 2006-03-30 |
KR20070057955A (ko) | 2007-06-07 |
US20060063756A1 (en) | 2006-03-23 |
CA2580610C (en) | 2013-07-09 |
JP5116092B2 (ja) | 2013-01-09 |
NZ580450A (en) | 2011-06-30 |
CN101039933A (zh) | 2007-09-19 |
JP2008513488A (ja) | 2008-05-01 |
DK1791830T3 (da) | 2011-04-18 |
RU2443700C2 (ru) | 2012-02-27 |
JP2009019048A (ja) | 2009-01-29 |
CY1112253T1 (el) | 2015-12-09 |
CN101039933B (zh) | 2012-06-06 |
US7329652B2 (en) | 2008-02-12 |
IL181987A0 (en) | 2007-07-04 |
RU2007114293A (ru) | 2008-10-27 |
CA2580610A1 (en) | 2006-03-30 |
PL1791830T3 (pl) | 2011-05-31 |
AU2005286968A1 (en) | 2006-03-30 |
ATE493401T1 (de) | 2011-01-15 |
SI1791830T1 (sl) | 2011-05-31 |
MX2007003154A (es) | 2007-05-15 |
EP1791830A1 (en) | 2007-06-06 |
EP1791830B1 (en) | 2010-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20071915L (no) | Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer | |
NO20074431L (no) | Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer | |
ATE542814T1 (de) | Pyrazinkinaseinhibitoren | |
MXPA06011327A (es) | Azaindoles utiles como inhibidores de jak y otras proteinas cinasas. | |
NO20072567L (no) | Triazoler nyttige som proteinkinase-inhibitorer | |
SG166828A1 (en) | Aminopyrimidines useful as kinase inhibitors | |
HK1113569A1 (en) | Pyrazolo | |
NO20084435L (no) | C-MET proteinkinaseinhibitorer | |
TW200514776A (en) | Aminotriazole compounds useful as inhibitors of protein kinases | |
TW200633980A (en) | Pyridones useful as inhibitors of kinases | |
HK1096673A1 (en) | Compositions useful as inhibitors of protein kinases | |
DE602007007985D1 (de) | Als inhibitoren von proteinkinasen geeignete aminopyrimidine | |
NO20080967L (no) | Benzimidazoler nyttige som inhibitorer av proteinkinaser | |
IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
MX2009005231A (es) | Composiciones utiles como inhibidores de proteina cinasa. | |
UA87494C2 (en) | Azaindoles useful as inhibitors of jak and other protein kinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |